None
Quote | Avenue Therapeutics Inc. (NASDAQ:ATXI)
Last: | $3.41 |
---|---|
Change Percent: | 0.0% |
Open: | $3.43 |
Close: | $3.41 |
High: | $3.46 |
Low: | $3.255 |
Volume: | 15,313 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Avenue Therapeutics Inc. (NASDAQ:ATXI)
MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced tha...
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the ...
Message Board Posts | Avenue Therapeutics Inc. (NASDAQ:ATXI)
Subject | By | Source | When |
---|---|---|---|
Just caught this. | subslover | investorshub | 04/17/2023 8:40:00 PM |
znewcar1: $ATXI Hod1.36 ML1.02 | znewcar1 | investorshangout | 04/05/2023 6:59:42 PM |
Avenue Therapeutics initiated by Aegis at buy. $32.00 | Rocketred | investorshub | 04/03/2023 9:56:09 PM |
GET YOUR CHEAP SHARES before they are gone | Rocketred | investorshub | 03/12/2023 11:34:38 PM |
$ATXI.......................https://stockcharts.com/h-sc/ui?s=$ATXI&p=W&b=5&g=0&id | glenn1919 | investorshub | 03/11/2023 1:01:38 PM |
News, Short Squeeze, Breakout and More Instantly...
Avenue Therapeutics Inc. Company Name:
ATXI Stock Symbol:
NASDAQ Market:
Avenue Therapeutics Inc. Website:
MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced tha...
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the ...
– Raised a total of $9.4 million in gross proceeds from warrant exercise transactions since January 2024 – MIAMI, May 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutica...